Literature DB >> 25851995

Response to hydroxyurea among Kuwaiti patients with sickle cell disease and elevated baseline HbF levels.

Adekunle Adekile1, Stephan Menzel2, Renu Gupta3,4, Sondus Al-Sharida5, Asma Farag5, Mohammad Haider1, Nagihan Akbulut5, Nada Mustafa1, Swee Lay Thein2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25851995     DOI： 10.1002/ajh.24027

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  7 in total

Review 1.  Genetic Modifiers of Fetal Haemoglobin in Sickle Cell Disease.

Authors:  Stephan Menzel; Swee Lay Thein
Journal:  Mol Diagn Ther       Date:  2019-04       Impact factor: 4.074

Review 2.  Osteonecrosis in sickle cell disease: an update on risk factors, diagnosis, and management.

Authors:  Oyebimpe O Adesina; Lynne D Neumayr
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

3.  Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea.

Authors:  Pierre Allard; Nareen Alhaj; Stephan Lobitz; Holger Cario; Andreas Jarisch; Regine Grosse; Lena Oevermann; Dani Hakimeh; Laura Tagliaferri; Elisabeth Kohne; Annette Kopp-Schneider; Andreas E Kulozik; Joachim B Kunz
Journal:  Haematologica       Date:  2022-07-01       Impact factor: 11.047

4.  Hydroxyurea: Pattern of Use, Patient Adherence, and Safety Profile in Patients with Sickle Cell Disease in Oman.

Authors:  Jimmy Jose; Refaat Abdullah Elsadek; Beena Jimmy; Prasad George
Journal:  Oman Med J       Date:  2019-07

5.  Association Between Selected Single Nucleotide Polymorphisms in Globin and Related Genes and Response to Hydroxyurea Therapy in Ghanaian Children with Sickle Cell Disease.

Authors:  Gloria Pokuaa Manu; Catherine Segbefia; Benoit Banga N'guessan; Shadrack Asiedu Coffie; George Obeng Adjei
Journal:  Pharmgenomics Pers Med       Date:  2022-03-10

Review 6.  The Genetic and Clinical Significance of Fetal Hemoglobin Expression in Sickle Cell Disease.

Authors:  Adekunle Adekile
Journal:  Med Princ Pract       Date:  2020-09-04       Impact factor: 1.927

7.  Diagnosis of Sickle Cell Disease and HBB Haplotyping in the Era of Personalized Medicine: Role of Next Generation Sequencing.

Authors:  Adekunle Adekile; Nagihan Akbulut-Jeradi; Rasha Al Khaldi; Maria Jinky Fernandez; Jalaja Sukumaran
Journal:  J Pers Med       Date:  2021-05-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.